174 related articles for article (PubMed ID: 22468711)
1. Phthalocyanine-peptide conjugates for epidermal growth factor receptor targeting.
Ongarora BG; Fontenot KR; Hu X; Sehgal I; Satyanarayana-Jois SD; Vicente MG
J Med Chem; 2012 Apr; 55(8):3725-38. PubMed ID: 22468711
[TBL] [Abstract][Full Text] [Related]
2. Targeting EGFR Overexpression at the Surface of Colorectal Cancer Cells by Exploiting Amidated BODIPY-Peptide Conjugates.
Williams TM; Zhou Z; Singh SS; Sibrian-Vazquez M; Jois SD; Henriques Vicente MDG
Photochem Photobiol; 2020 May; 96(3):581-595. PubMed ID: 32086809
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Characterization, and Evaluation of Near-IR Boron Dipyrromethene Bioconjugates for Labeling of Adenocarcinomas by Selectively Targeting the Epidermal Growth Factor Receptor.
Kaufman NEM; Meng Q; Griffin KE; Singh SS; Dahal A; Zhou Z; Fronczek FR; Mathis JM; Jois SD; Vicente MGH
J Med Chem; 2019 Apr; 62(7):3323-3335. PubMed ID: 30835998
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of BODIPY-Peptide Conjugates for Fluorescence Labeling of EGFR Overexpressing Cells.
Zhao N; Williams TM; Zhou Z; Fronczek FR; Sibrian-Vazquez M; Jois SD; Vicente MGH
Bioconjug Chem; 2017 May; 28(5):1566-1579. PubMed ID: 28414435
[TBL] [Abstract][Full Text] [Related]
5. Facile Synthesis of Cyclic Peptide-Phthalocyanine Conjugates for Epidermal Growth Factor Receptor-Targeted Photodynamic Therapy.
Chu JCH; Fong WP; Wong CTT; Ng DKP
J Med Chem; 2021 Feb; 64(4):2064-2076. PubMed ID: 33577327
[TBL] [Abstract][Full Text] [Related]
6. Click Conjugation of Boron Dipyrromethene (BODIPY) Fluorophores to EGFR-Targeting Linear and Cyclic Peptides.
Williams TM; Kaufman NEM; Zhou Z; Singh SS; Jois SD; Vicente MDGH
Molecules; 2021 Jan; 26(3):. PubMed ID: 33498632
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of [
Li X; Hu K; Liu W; Wei Y; Sha R; Long Y; Han Y; Sun P; Wu H; Li G; Tang G; Huang S
Nucl Med Biol; 2020; 90-91():84-92. PubMed ID: 33189948
[TBL] [Abstract][Full Text] [Related]
8. Zwitterionic near-infrared fluorophore-conjugated epidermal growth factor for fast, real-time, and target-cell-specific cancer imaging.
Kim H; Cho MH; Choi HS; Lee BI; Choi Y
Theranostics; 2019; 9(4):1085-1095. PubMed ID: 30867817
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor (EGFR) density may not be the only determinant for the efficacy of EGFR-targeted photoimmunotherapy in human head and neck cancer cell lines.
Peng W; de Bruijn HS; Farrell E; Sioud M; Mashayekhi V; Oliveira S; van Dam GM; Roodenburg JLN; Witjes MJH; Robinson DJ
Lasers Surg Med; 2018 Jul; 50(5):513-522. PubMed ID: 29777587
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
[TBL] [Abstract][Full Text] [Related]
11. Targeting of the epidermal growth factor receptor with mesoporphyrin IX-peptide conjugates.
Fontenot KR; Ongarora BG; LeBlanc LE; Zhou Z; Jois SD; Vicente MG
J Porphyr Phthalocyanines; 2016 Jan; 20(1-4):352-366. PubMed ID: 27738394
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor-targeted molecular imaging of colorectal tumors: Detection and treatment evaluation of tumors in animal models.
Miyamoto Y; Muguruma N; Fujimoto S; Okada Y; Kida Y; Nakamura F; Tanaka K; Nakagawa T; Kitamura S; Okamoto K; Miyamoto H; Sato Y; Takayama T
Cancer Sci; 2019 Jun; 110(6):1921-1930. PubMed ID: 30973663
[TBL] [Abstract][Full Text] [Related]
13. In silico studies of interactions of peptide-conjugated cholesterol metabolites and betulinic acid with EGFR, LDR, and N-terminal fragment of CCKA receptors.
Bashant MM; Mitchell SM; Hart LR; Lebedenko CG; Banerjee IA
J Mol Model; 2021 Dec; 28(1):16. PubMed ID: 34961887
[TBL] [Abstract][Full Text] [Related]
14. Exploring pitfalls of
Striese F; Sihver W; Gao F; Bergmann R; Walther M; Pietzsch J; Steinbach J; Pietzsch HJ
Amino Acids; 2018 Oct; 50(10):1415-1431. PubMed ID: 30039310
[TBL] [Abstract][Full Text] [Related]
15. Peptide ligands for targeting the extracellular domain of EGFR: Comparison between linear and cyclic peptides.
Williams TM; Sable R; Singh S; Vicente MGH; Jois SD
Chem Biol Drug Des; 2018 Feb; 91(2):605-619. PubMed ID: 29052959
[TBL] [Abstract][Full Text] [Related]
16. Optimization of a nanomedicine-based silicon phthalocyanine 4 photodynamic therapy (Pc 4-PDT) strategy for targeted treatment of EGFR-overexpressing cancers.
Master AM; Livingston M; Oleinick NL; Sen Gupta A
Mol Pharm; 2012 Aug; 9(8):2331-8. PubMed ID: 22775587
[TBL] [Abstract][Full Text] [Related]
17. An optical probe for noninvasive molecular imaging of orthotopic brain tumors overexpressing epidermal growth factor receptor.
Agnes RS; Broome AM; Wang J; Verma A; Lavik K; Basilion JP
Mol Cancer Ther; 2012 Oct; 11(10):2202-11. PubMed ID: 22807580
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo assessment of targeting lipid-based nanoparticles to the epidermal growth factor-receptor (EGFR) using a novel Heptameric ZEGFR domain.
Benhabbour SR; Luft JC; Kim D; Jain A; Wadhwa S; Parrott MC; Liu R; DeSimone JM; Mumper RJ
J Control Release; 2012 Feb; 158(1):63-71. PubMed ID: 22037106
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and properties of cell-targeted Zn(II)-phthalocyanine-peptide conjugates.
Sibrian-Vazquez M; Ortiz J; Nesterova IV; Fernandez-Lazaro F; Sastre-Santos A; Soper SA; Vicente MG
Bioconjug Chem; 2007; 18(2):410-20. PubMed ID: 17279788
[TBL] [Abstract][Full Text] [Related]
20. An EGFR-targeting antibody-drug conjugate LR004-VC-MMAE: potential in esophageal squamous cell carcinoma and other malignancies.
Hu XY; Wang R; Jin J; Liu XJ; Cui AL; Sun LQ; Li YP; Li Y; Wang YC; Zhen YS; Miao QF; Li ZR
Mol Oncol; 2019 Feb; 13(2):246-263. PubMed ID: 30372581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
